IDOV-Immune vaccine for advanced solid tumors
Part of Cancer, Digestive system, Hormones & metabolism, Infections, Kidney & urinary, Lungs & breathing, Skin, Women’s health & pregnancy clinical trials.
This trial tests an experimental virus-based treatment for people with advanced solid tumors that have stopped responding to standard therapies. The treatment is designed to infect and destroy cancer cells while boosting the immune system.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have advanced solid tumors that no longer respond to standard treatments or for which no standard treatment exists.
- You are in fairly good health (ECOG score 0 or 1).
- Your cancer can be measured on scans.
- You have not been treated with a similar virus therapy before.
- You do not have an active serious infection, autoimmune disease, or unstable brain metastases.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational cell therapy, IOV-5001, in adults with certain advanced cancers (lung, breast, colorectal, or head and neck). The therapy uses a patient's own immune cells to target the tumor, and the study aims to see if it can slow or stop cancer growth.
This trial tests a new treatment where a virus (GC001) is injected directly into a tumor. The virus is designed to attack cancer cells and may help people with advanced solid tumors that haven't responded to other treatments.
This trial tests a new virus-based treatment for advanced melanoma that has spread to the brain or other parts of the body. The virus is injected directly into a tumor to try to kill it, and it may boost your immune system against the cancer.
This trial tests a modified virus injected directly into tumors to treat metastatic gastrointestinal and peritoneal cancers. It aims to see if this approach can shrink tumors or slow their growth.
This trial tests an investigational drug called IDOV-Immune for people with advanced solid tumors that have stopped responding to standard treatments. The goal is to see if it is safe and effective.
This trial tests a new intravenous drug called IDOV-SAFE in people with advanced solid tumors that have stopped responding to standard treatments or have no effective standard option. The goal is to see if it is safe and effective.
Hear when a new Colorectal cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.